{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:04:02Z","timestamp":1793232242765,"version":"4.5.0"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD104656"],"award-info":[{"award-number":["R01HD104656"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>\n                    Benzodiazepines have been in use for over half a century. While they remain highly prescribed, their unfavorable side-effect profile and abuse liability motivated a search for alternatives. Most of these efforts focused on the development of benzodiazepine-like drugs that are selective for specific GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor subtypes. While there is ample evidence that subtype-selective GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor ligands have great potential for providing symptom relief without typical benzodiazepine side-effects, it is less clear whether subtype-selective targeting strategies can also reduce misuse and abuse potential. This review focuses on the three benzodiazepine properties that are relevant to the DSM-5-TR criteria for Sedative, Hypnotic, or Anxiolytic Use Disorder, namely, reinforcing properties of benzodiazepines, maladaptive behaviors related to benzodiazepine use, and benzodiazepine tolerance and dependence. We review existing evidence regarding the involvement of different GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor subtypes in each of these areas. The reviewed studies suggest that \u03b11-containing GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors play an integral role in benzodiazepine-induced plasticity in reward-related brain areas and might be involved in the development of tolerance and dependence to benzodiazepines. However, a systematic comparison of the contributions of all benzodiazepine-sensitive GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptors to these processes, a mechanistic understanding of how the positive modulation of each receptor subtype might contribute to the brain mechanisms underlying each of these processes, and a definitive answer to the question of whether specific chronic modulation of any given subtype would result in some or all of the benzodiazepine effects are currently lacking from the literature. Moreover, how non-selective benzodiazepines might lead to the maladaptive behaviors listed in DSM and how different GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor subtypes might be involved in the development of these behaviors remains unexplored. Considering the increasing burden of benzodiazepine abuse, the common practice of benzodiazepine misuse that leads to severe dependence, and the current efforts to generate side-effect free benzodiazepine alternatives, there is an urgent need for systematic, mechanistic research that provides a better understanding of the brain mechanisms of benzodiazepine misuse and abuse, including the involvement of specific GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor subtypes in these processes, to establish an informed foundation for preclinical and clinical efforts.\n                  <\/jats:p>","DOI":"10.3389\/fpsyt.2022.1060949","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T01:18:31Z","timestamp":1673486311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["GABAA receptor subtypes and benzodiazepine use, misuse, and abuse"],"prefix":"10.3389","volume":"13","author":[{"given":"Elif","family":"Engin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","unstructured":"FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0047.2004.00325.x","article-title":"Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"109","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand Suppl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B4","first-page":"18","volume-title":"Non-medical use of benzodiazepines: A growing threat to public health? Global Smart Update.","year":"2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/bcp.13959","article-title":"Nonmedical use of alprazolam in the UK: Results from a nationally representative survey","volume":"85","author":"Hockenhull","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/bcp.14397","article-title":"Nonmedical use of benzodiazepines and Z-drugs in the UK","volume":"87","author":"Hockenhull","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/bcp.14537","article-title":"Non-medical use of benzodiazepines and GABA analogues in Europe","volume":"87","author":"Hockenhull","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/dar.13086","article-title":"Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014-2017)","volume":"39","author":"Zheng","year":"2020","journal-title":"Drug Alcohol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABA(A) receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discor."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"GABAA Receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABA","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.sbi.2019.03.023","article-title":"A structural perspective on GABA","volume":"54","author":"Scott","year":"2019","journal-title":"Curr Opin Struct Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3389\/fneur.2019.01407","article-title":"Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function","volume":"10","author":"Liu","year":"2020","journal-title":"Front Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0028-3908(02)00159-4","article-title":"Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists","volume":"43","author":"Crestani","year":"2002","journal-title":"Neuropharmacology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17154","DOI":"10.1073\/pnas.0508752102","article-title":"A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction","volume":"102","author":"Yee","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1111\/j.1460-9568.2004.03642.x","article-title":"GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear","volume":"20","author":"Yee","year":"2004","journal-title":"Eur J Neuroscie."},{"key":"B20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","article-title":"Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice","volume":"63","author":"Smith","year":"2012","journal-title":"Neuropharmacology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13698","DOI":"10.1523\/JNEUROSCI.1370-15.2015","article-title":"Tonic inhibitory control of dentate gyrus granule cells by alpha5-containing GABAA receptors reduces memory interference","volume":"35","author":"Engin","year":"2015","journal-title":"J Neuroscience."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e14120","DOI":"10.7554\/eLife.14120","article-title":"Modulation of anxiety and fear via distinct intrahippocampal circuits","volume":"5","author":"Engin","year":"2016","journal-title":"Elife."},{"key":"B23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1101\/lm.052084.120","article-title":"Bidirectional regulation of distinct memory domains by \u03b15-subunit-containing GABA","volume":"27","author":"Engin","year":"2020","journal-title":"Learn Mem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/npp.2014.41","article-title":"Neural basis of benzodiazepine reward: requirement for alpha2 containing GABAA receptors in the nucleus accumbens","volume":"39","author":"Engin","year":"2014","journal-title":"Neuropsychopharmacology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic 'restriction-of-function' approach reveals evidence for anxiolytic-like actions mediated by alpha5-containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tips.2009.05.007","article-title":"GABAergic analgesia: new insights from mutant mice and subtype-selective agonists","volume":"30","author":"Zeilhofer","year":"2009","journal-title":"Trends Pharmacol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABA(A) receptor subtype","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","article-title":"Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders","volume":"26","author":"Pr\u00e9vot","year":"2021","journal-title":"Mol Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41386-021-01144-w","volume":"46","author":"Benham","year":"2021","journal-title":"Neuropsychopharmacology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41386-022-01360-y","article-title":"Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress","volume":"47","author":"Bernardo","year":"2022","journal-title":"Neuropsychopharmacology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype selective \u03b3-aminobutyric acid type a receptor (GABAAR) modulators acting at the benzodiazepine binding site: an update","volume":"63","author":"Maramai","year":"2020","journal-title":"J Med Chem."},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and Statistical Manual of Mental Disorders.","author":"Association","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals\u2013implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology (Berl)."},{"key":"B35","first-page":"28","article-title":"Benzodiazepine use, abuse, and dependence","volume":"66","author":"O'brien","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"B37","doi-asserted-by":"publisher","first-page":"811130","DOI":"10.3389\/fpsyt.2022.811130","article-title":"Polysubstance use patterns among high dose benzodiazepine users: a latent class analysis and differences between male and female use","volume":"13","author":"Zamboni","year":"2022","journal-title":"Front Psychiatry."},{"key":"B38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20236","article-title":"Designer benzodiazepines: A new challenge","volume":"14","author":"Moosmann","year":"2015","journal-title":"World Psychiatry."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0142057","DOI":"10.1371\/journal.pone.0142057","article-title":"High-dose benzodiazepine dependence: a qualitative study of patients' perceptions on initiation, reasons for use, and obtainment","volume":"10","author":"Liebrenz","year":"2015","journal-title":"PLoS ONE."},{"key":"B40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0976-0105.152090","article-title":"Off-label drug use in Psychiatry Outpatient Department: A prospective study at a Tertiary Care Teaching Hospital","volume":"6","author":"Kharadi","year":"2015","journal-title":"J Basic Clin Pharm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000502518","article-title":"Call for action: benzodiazepine prescription prevalence analysis shows off-label prescription in one in eleven citizens","volume":"25","author":"L\u00f3pez-Pelayo","year":"2019","journal-title":"Eur Addict Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12991-018-0176-4","article-title":"Off-label prescription of psychiatric drugs by non-psychiatrist physicians in three general hospitals in Germany","volume":"17","author":"L\u00fccke","year":"2018","journal-title":"Ann Gen Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0198363","DOI":"10.1371\/journal.pone.0198363","article-title":"Patterns and predictors of off-label prescription of psychiatric drugs","volume":"13","author":"Vijay","year":"2018","journal-title":"PLoS ONE."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1176\/appi.ps.201500380","article-title":"Sustained use of benzodiazepines and escalation to high doses in a Canadian population","volume":"67","author":"Alessi-Severini","year":"2016","journal-title":"Psychiatr Serv."},{"key":"B45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/fampra\/cmt010","article-title":"Tolerance to benzodiazepines among long-term users in primary care","volume":"30","author":"Willems","year":"2013","journal-title":"Fam Pract."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr Pharm Des."},{"key":"B47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/fampra\/13.6.491","article-title":"The long-term use of benzodiazepines: patients' views, accounts and experiences","volume":"13","author":"Barter","year":"1996","journal-title":"Fam Pract."},{"key":"B48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/13651500903447810","article-title":"Usage of benzodiazepines: A review","volume":"14","author":"Donoghue","year":"2010","journal-title":"Int J Psychiatry Clin Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2013will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction."},{"key":"B52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits. A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J Psychopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/add.15695","article-title":"Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications","volume":"117","author":"Baldwin","year":"2022","journal-title":"Addiction."},{"key":"B54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr Serv."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20451253221082386","article-title":"Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survery","volume":"12","author":"Finlayson","year":"2022","journal-title":"Therap Adv Psychopharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.addbeh.2004.01.001","article-title":"Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication","volume":"29","author":"O'Connor","year":"2004","journal-title":"Addict Behav."},{"key":"B57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpsychires.2003.10.003","article-title":"Chronic benzodiazepine usage and withdrawal in insomnia patients","volume":"38","author":"Poyares","year":"2004","journal-title":"J Psychiatr Res."},{"key":"B58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0962728600026634","article-title":"Housing conditions affect self-administration of anxiolytic by laboratory mice","volume":"13","author":"Sherwin","year":"2004","journal-title":"Animal Welfare."},{"key":"B59","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature."},{"key":"B60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00431813","article-title":"Diazepam-induced place preference conditioning: appetitive and antiaversive properties","volume":"87","author":"Spyraki","year":"1985","journal-title":"Psychopharmacology (Berl)."},{"key":"B62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol Biochem Behav."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/npp.2012.115","article-title":"Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward","volume":"37","author":"Reynolds","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/FBP.0000000000000464","article-title":"Effects of the \u03b12\/\u03b13-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam","volume":"30","author":"Moerke MJ Li","year":"2019","journal-title":"Behav Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yhbeh.2009.11.009","article-title":"Mixing pleasures: review of the effects of drugs on sex behavior in humans and animal models","volume":"58","author":"Frohmader","year":"2010","journal-title":"Horm Behav."},{"key":"B66","first-page":"1199","article-title":"Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal","volume":"260","author":"Griffiths","year":"1992","journal-title":"J Pharmacol Exp Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1037\/1064-1297.15.4.328","article-title":"Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses","volume":"15","author":"Rowlett","year":"2007","journal-title":"Exp Clin Psychopharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/npp.2012.265","article-title":"Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys","volume":"38","author":"Shinday","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"B70","first-page":"220","article-title":"Human preference comparison of pentobarbital, diazepam, and placebo","volume":"34","author":"Griffiths","year":"1981","journal-title":"NIDA Res Monogr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/BF02244196","article-title":"Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons","volume":"103","author":"Griffiths","year":"1991","journal-title":"Psychopharmacology (Berl)."},{"key":"B72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mcna.2021.08.012","article-title":"L, Laevander X. A benzodiazepines and related sedatives","volume":"106","author":"Peng","year":"2022","journal-title":"Med Clin North America."},{"key":"B73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1124\/jpet.109.158303","article-title":"Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2\/3 subtypes","volume":"332","author":"Ator","year":"2010","journal-title":"J Pharmacol Exp Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00213-014-3473-x","article-title":"The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam","volume":"231","author":"Wright","year":"2014","journal-title":"Psychopharmacology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/FBP.0b013e3282d28f2b","article-title":"Benzodiazepine-induced hippocampal CA1 neuron alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA) receptor plasticity linked to severity of withdrawal anxiety: differential role of voltage-gated calcium channels and N-methyl-D-aspartic acid receptors","volume":"18","author":"Xiang","year":"2007","journal-title":"Behav Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/syn.20700","article-title":"Changes in hippocampal arc protein expression and synaptic plasticity by the presentation of contextual cues linked to drug experience","volume":"64","author":"Monti","year":"2010","journal-title":"Synapse."},{"key":"B77","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2015.10.026","article-title":"Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis","volume":"158","author":"Fischer","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00213-017-4615-8","article-title":"Abuse-related effects of subtype-selective GABA","volume":"234","author":"Schwienteck KL Li","year":"2017","journal-title":"Psychopharmacology (Berl)."},{"key":"B79","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1523\/JNEUROSCI.1195-18.2018","article-title":"Neuronal ensemble in the rostral agranular insula tracks cocaine-induced devaluation of natural reward and predicts cocaine seeking","volume":"38","author":"Moschak","year":"2018","journal-title":"J Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1037\/0735-7044.116.2.321","article-title":"Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards","volume":"116","author":"Grigson","year":"2002","journal-title":"Behav Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainresbull.2017.09.008","article-title":"Heroin-induced suppression of saccharin intake in OPRM1 A118G mice","volume":"138","author":"Freet","year":"2018","journal-title":"Brain Res Bull."},{"key":"B82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainresbull.2015.11.009","article-title":"Reward devaluation and heroin escalation is associated with differential expression of CRF signaling genes","volume":"123","author":"McFalls","year":"2016","journal-title":"Brain Res Bull."},{"key":"B83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ddmod.2009.03.005","article-title":"Reward Comparison: The Achilles' heel and hope for addiction","volume":"5","author":"Grigson","year":"2008","journal-title":"Drug Discov Today Dis Models."},{"key":"B84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0149-7634(94)00028-Y","article-title":"Rewarding drugs produce taste avoidance, but not taste aversion","volume":"19","author":"Parker","year":"1995","journal-title":"Neurosci Biobehav Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0149-7634(94)00026-W","article-title":"Benzodiazepines, appetite, and taste palatability","volume":"19","author":"Berridge","year":"1995","journal-title":"Neurosci Biobehav Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0149-7634(05)80139-3","article-title":"Interacting effects of oxazepam in late pregnancy and fostering procedure on mouse maternal behavior","volume":"15","author":"Laviola","year":"1991","journal-title":"Neurosci Biobehav Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0091-3057(00)00211-2","article-title":"Inhibitory effect of buspirone and diazepam, but not of 8-OH-DPAT, on maternal behavior and aggression","volume":"66","author":"Ferreira","year":"2000","journal-title":"Pharmacol Biochem Behav."},{"key":"B88","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-007-0951-4","article-title":"Modulation of human risky decision making by flunitrazepam","volume":"196","author":"Lane","year":"2008","journal-title":"Psychopharmacology (Berl)."},{"key":"B89","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00213-005-2265-8","article-title":"Acute effects of alprazolam on risky decision making in humans","volume":"181","author":"Lane","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"B90","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00213-006-0519-8","article-title":"Lorazepam dose-dependently decreases risk-taking related activation in limbic areas","volume":"189","author":"Arce","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"B91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0376-8716(92)90005-W","article-title":"Benzodiazepine use and HIV risk-taking behaviour among injecting drug users","volume":"31","author":"Darke","year":"1992","journal-title":"Drug Alcohol Depend."},{"key":"B92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1753-6405.1993.tb00097.x","article-title":"Factors associated with heroin users' AIDS risk-taking behaviours","volume":"17","author":"Caplehorn","year":"1993","journal-title":"Aust J Public Health."},{"key":"B93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1744-9081-6-24","article-title":"Dopamine signals for reward value and risk: basic and recent data","volume":"6","author":"Schultz","year":"2010","journal-title":"Behav Brain Functions"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/npp.2008.89","article-title":"Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists","volume":"34","author":"Heikkinen","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","article-title":"Molecular diversity and specializations among the cells of the adult mouse brain","volume":"174","author":"Saunders","year":"2018","journal-title":"Cell."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.psyneuen.2003.11.004","article-title":"Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression","volume":"29","author":"Wichniak","year":"2004","journal-title":"Psychoneuroendocrinology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41380-020-0683-y","article-title":"Nucleus accumbens fast-spiking interneurons in motivational and addictive behaviors","volume":"26","author":"Schall","year":"2020","journal-title":"Molecular Psychiatry"},{"key":"B100","first-page":"109","article-title":"Self-stimulation: A rewarding decade","volume":"16","author":"Bielajew","year":"1991","journal-title":"J Psychiat Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Compar Neurol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.01.008","article-title":"Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain","volume":"236","author":"H\u00f6rtnagl","year":"2013","journal-title":"Neuroscience."},{"key":"B103","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience."},{"key":"B104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0306-4522(97)00634-9","article-title":"Expression of 10 GABA(A) receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry","volume":"85","author":"Kultas-Ilinsky","year":"1998","journal-title":"Neuroscience."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/cne.24910","article-title":"Immunohistochemical distribution of 10 GABA(A) receptor subunits in the forebrain of the rhesus monkey Macaca mulatta","volume":"528","author":"Sperk","year":"2020","journal-title":"J Comp Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fncel.2014.00415","article-title":"GABA-A and NMDA receptor subunit mRNA expression is altered in the caudate but not the putamen of the postmortem brains of alcoholics","volume":"8","author":"Bhandage","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/cercor\/5.6.550","article-title":"GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls","volume":"5","author":"Akbarian","year":"1995","journal-title":"Cereb Cortex."},{"key":"B108","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02244183","article-title":"Chronic benzodiazepine administration. VII Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration","volume":"104","author":"Galpern","year":"1991","journal-title":"Psychopharmacology (Berl)."},{"key":"B109","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000139531","article-title":"The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation","volume":"55","author":"Koff","year":"1997","journal-title":"Pharmacology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0091-3057(97)00539-X","article-title":"Benzodiazepine dependence: from neural circuits to gene expression","volume":"59","author":"Pratt","year":"1998","journal-title":"Pharmacol Biochem Behav."},{"key":"B111","doi-asserted-by":"publisher","first-page":"416864","DOI":"10.1155\/2012\/416864","article-title":"Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators?","volume":"2012","author":"Vinkers","year":"2012","journal-title":"Adv Pharmacol Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","article-title":"Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?","volume":"109","author":"Gravielle","year":"2016","journal-title":"Pharmacol Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00213-019-05447-1","article-title":"Tolerance and dependence following chronic alprazolam treatment: quantitative observation studies in female rhesus monkeys","volume":"237","author":"Duke","year":"2020","journal-title":"Psychopharmacology (Berl)."},{"key":"B114","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0149-7634(85)90037-5","article-title":"Tolerance to the behavioral actions of benzodiazepines","volume":"9","author":"File","year":"1985","journal-title":"Neurosci Biobehav Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(93)90567-2","article-title":"Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems","volume":"230","author":"Ishihara","year":"1993","journal-title":"Eur J Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.pnpbp.2009.05.018","article-title":"Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand","volume":"33","author":"Kita","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B117","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2015.09.038","article-title":"Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex","volume":"310","author":"Ferreri","year":"2015","journal-title":"Neuroscience."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e43054","DOI":"10.1371\/journal.pone.0043054","article-title":"GABAA receptor a subunits differentially contribute to diazepam tolerance after chronic treatment","volume":"7","author":"Vinkers","year":"2012","journal-title":"PLoS ONE."},{"key":"B119","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jama.250.6.767","article-title":"Long-term diazepam therapy and clinical outcome","volume":"250","author":"Rickels","year":"1983","journal-title":"JAMA."},{"key":"B120","first-page":"18","article-title":"Long-term pharmacologic treatment of panic disorder","volume":"52","author":"Ballenger","year":"1991","journal-title":"J Clin Psychiatry."},{"key":"B121","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/j.1875-9114.1984.tb03327.x","article-title":"Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder","volume":"4","author":"Cohn","year":"1984","journal-title":"Pharmacotherapy."},{"key":"B122","first-page":"424","article-title":"The behavioral effects of benzodiazepines following long-term use","volume":"22","author":"Lucki","year":"1986","journal-title":"Psychopharmacol Bull."},{"key":"B123","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/BF00178503","article-title":"Chronic use of benzodiazepines and psychomotor and cognitive test performance","volume":"88","author":"Lucki","year":"1986","journal-title":"Psychopharmacology (Berl)."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0028-3908(96)00071-8","article-title":"Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction","volume":"35","author":"Longone","year":"1996","journal-title":"Neuropharmacology."},{"key":"B125","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pnpbp.2014.08.014","article-title":"Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors","volume":"56","author":"Pomara","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B126","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","article-title":"Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study","volume":"22","author":"Paterniti","year":"2002","journal-title":"J Clin Psychopharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/hup.226","article-title":"Self-report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance","volume":"15","author":"McAndrews","year":"2000","journal-title":"Hum Psychopharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of 5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"The J Neuroscience."},{"key":"B129","doi-asserted-by":"publisher","first-page":"108985","DOI":"10.1016\/j.drugalcdep.2021.108985","article-title":"Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABA","volume":"228","author":"Duke","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B130","doi-asserted-by":"publisher","first-page":"e00416","DOI":"10.1002\/prp2.416","article-title":"Potential role for histone deacetylation in chronic diazepam-induced downregulation of alpha1-GABAA receptor subunit expression","volume":"6","author":"Auta","year":"2018","journal-title":"Pharmacol Res Perspect."},{"key":"B131","first-page":"298","article-title":"Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem","volume":"263","author":"Perrault","year":"1992","journal-title":"J Pharmacol Exp Ther."},{"key":"B132","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0091-3057(00)00176-3","article-title":"Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem","volume":"66","author":"Elliot","year":"2000","journal-title":"Pharmacol Biochem Behav."},{"key":"B133","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF00174367","article-title":"The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic","volume":"89","author":"Sanger","year":"1986","journal-title":"Psychopharmacology (Berl)."},{"key":"B134","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF00175198","article-title":"Response decrement patterns after neuroleptic and non-neuroleptic drugs","volume":"89","author":"Sanger","year":"1986","journal-title":"Psychopharmacology (Berl)."},{"key":"B135","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1081\/ADA-120020513","article-title":"Differential effects in humans after repeated administrations of zolpidem and triazolam","volume":"29","author":"Stoops","year":"2003","journal-title":"Am J Drug Alcohol Abuse."},{"key":"B136","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pbb.2008.01.021","article-title":"Gaboxadol \u2013 a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing","volume":"90","author":"Ebert","year":"2008","journal-title":"Pharmacol Biochem Behav."},{"key":"B137","first-page":"814","article-title":"Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia","volume":"12","author":"Hoehns","year":"1993","journal-title":"Clin Pharm."},{"key":"B138","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/030006059101900313","article-title":"Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients","volume":"19","author":"Schlich","year":"1991","journal-title":"J Int Med Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/0269881109354927","article-title":"MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1176\/appi.ps.54.7.1006","article-title":"Lack of relationship between long-term use of benzodiazepines and escalation to high dosages","volume":"54","author":"Soumerai","year":"2003","journal-title":"Psychiatr Serv."},{"key":"B141","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1192\/bjp.2020.164","article-title":"Benzodiazepines: it's time to return to the evidence","volume":"218","author":"Silberman","year":"2021","journal-title":"Br J Psychiatry."},{"key":"B142","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s002130100784","article-title":"Alprazolam withdrawal and tolerance measured in the social conflict test in mice","volume":"157","author":"Votava","year":"2001","journal-title":"Psychopharmacology (Berl)."},{"key":"B143","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0169-328X(01)00164-4","article-title":"Increase in expression of the GABA receptor a subunit gene A 4 induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists","volume":"92","author":"Follesa","year":"2001","journal-title":"Molec Brain Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/PAF.0b013e3181875aa0","article-title":"fatal case of benzodiazepine withdrawal","volume":"30","author":"Lann","year":"2009","journal-title":"Am J Forensic Med Pathol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Soyka","year":"2017","journal-title":"N Engl J Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/2045125317753340","article-title":"Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation","volume":"8","author":"Fluyau","year":"2018","journal-title":"Therap Adv Psychopharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B148","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1124\/pr.109.002063","article-title":"Regulation of GABAA receptor subunit expression by pharmacological agents","volume":"62","author":"Uusi-Oukari","year":"2010","journal-title":"Pharmacol Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0028-3908(96)00064-0","article-title":"Chronic treatment with diazepam or abecarnil differentially affects the expression of GABAA receptor subunit mRNAs in the rat cortex","volume":"35","author":"Holt","year":"1996","journal-title":"Neuropharmacology."},{"key":"B150","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0169-328X(97)00129-0","article-title":"Chronic diazepam exposure decreases transcription of the rat GABA(A) receptor gamma2-subunit gene","volume":"48","author":"Holt","year":"1997","journal-title":"Brain Res Mol Brain Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1046\/j.1471-4159.1999.0722219.x","article-title":"Decreased GABA enhancement of benzodiazepine binding after a single dose of diazepam","volume":"72","author":"Holt","year":"1999","journal-title":"J Neurochem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/BF02736732","article-title":"Reduced expression of gamma-aminobutyric acid type A\/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats","volume":"45","author":"Zhao","year":"1994","journal-title":"Mol Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0014-2999(89)90747-4","article-title":"Regional GABA\/benzodiazepine receptor\/chloride channel coupling after acute and chronic benzodiazepine treatment","volume":"167","author":"Tietz","year":"1989","journal-title":"Eur J Pharmacol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02821559","article-title":"Expression of alpha(1), alpha(5), and gamma(2) GABA(A) receptor subunit messenger RNAs as measured in situ in rat hippocampus and cortex following chronic flurazepam administration","volume":"4","author":"Tietz","year":"1993","journal-title":"J Molec Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0028-3908(01)00167-8","article-title":"Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem","volume":"42","author":"Follesa","year":"2002","journal-title":"Neuropharmacology."},{"key":"B156","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0163-7258(03)00029-9","article-title":"Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence","volume":"98","author":"Allison","year":"2003","journal-title":"Pharmacol Ther."},{"key":"B157","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cne.21866","article-title":"Increased AMPA receptor glur1subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal","volume":"511","author":"Das","year":"2008","journal-title":"J Comp Neurol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1002\/cne.22458","article-title":"Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal","volume":"518","author":"Das","year":"2010","journal-title":"J Comp Neurol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1124\/jpet.110.174235","article-title":"Down-regulation of synaptic GluN2B Subunit-Containing N-methyl-D-aspartate receptors: a physiological brake on CA1 Neuron -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal","volume":"336","author":"Shen","year":"2011","journal-title":"J Pharmacol Exper Therap."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/npp.2010.61","article-title":"Calcium\/calmodulin-dependent protein kinase ii mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal","volume":"35","author":"Shen","year":"2010","journal-title":"Neuropsychopharmacology."},{"key":"B161","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1124\/jpet.107.121798","article-title":"Benzodiazepine withdrawal-induced glutamatergic plasticity involves up-regulation of GluR1-containing alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in hippocampal CA1 neurons","volume":"322","author":"Song","year":"2007","journal-title":"J Pharmacol Exper Therap."},{"key":"B162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pbb.2008.12.015","article-title":"Reduced benzodiazepine tolerance, but increased flumazenil-precipitated withdrawal in AMPA-receptor GluR-A subunit-deficient mice","volume":"92","author":"Vekovischeva","year":"2009","journal-title":"Pharmacol. Biochem Behav."},{"key":"B163","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000346440","article-title":"Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence","volume":"91","author":"Okamoto","year":"2013","journal-title":"Pharmacology."},{"key":"B164","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1073\/pnas.90.14.6889","article-title":"Diazepam dependence prevented by glutamate antagonists","volume":"90","author":"Steppuhn","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B165","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0028-3908(02)00152-1","article-title":"Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression(1)","volume":"43","author":"Van Sickle","year":"2002","journal-title":"Neuropharmacology."},{"key":"B166","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0028-3908(02)00065-5","article-title":"Selective enhancement of AMPA receptor-mediated function in hippocampal CA1 neurons from chronic benzodiazepine-treated rats","volume":"43","author":"Van Sickle","year":"2002","journal-title":"Neuropharmacology."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/sj.npp.1300531","article-title":"Transient plasticity of hippocampal CA1 neuron glutamate receptors contributes to benzodiazepine withdrawal-anxiety","volume":"29","author":"Van Sickle","year":"2004","journal-title":"Neuropsychopharmacology."},{"key":"B168","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S1734-1140(11)70579-5","article-title":"Effect of nitric oxide synthase inhibitors on benzodiazepine withdrawal in mice and rats","volume":"63","author":"Talarek","year":"2011","journal-title":"Pharmacol Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2005.07.025","article-title":"Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice","volume":"523","author":"Listos","year":"2005","journal-title":"Eur J Pharmacol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1476-5381.1992.tb14201.x","article-title":"The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988","volume":"105","author":"Singh","year":"1992","journal-title":"Br J Pharmacol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/gbb.12321","article-title":"GABA(A) receptor subtype involvement in addictive behaviour","volume":"16","author":"Stephens","year":"2017","journal-title":"Genes Brain Behav."},{"key":"B172","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.pharmthera.2006.05.004","article-title":"Low dose acute alcohol effects on GABA A receptor subtypes","volume":"112","author":"Wallner","year":"2006","journal-title":"Pharmacol Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.alcohol.2007.04.006","article-title":"receptor subtypes: the \u201cone glass of wine\u201d receptors","volume":"41","author":"Olsen","year":"2007","journal-title":"Alcohol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1523\/JNEUROSCI.4702-05.2006","article-title":"Chronic intermittent ethanol-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABAA receptors","volume":"26","author":"Liang","year":"2006","journal-title":"J Neurosci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fpsyt.2018.00468","article-title":"Chronic alcohol treatment-induced GABA-Aalpha5 Histone H3K4 trimethylation upregulation leads to increased GABA-Aalpha5 expression and susceptibility to alcohol addiction in the offspring of wistar rats","volume":"9","author":"Zeng","year":"2018","journal-title":"Front Psychiatry."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/ijnp\/pyx075","article-title":"Emerging role of one-carbon metabolism and DNA methylation enrichment on delta-containing GABAA receptor expression in the cerebellum of subjects with alcohol use disorders (AUD)","volume":"20","author":"Gatta","year":"2017","journal-title":"Int J Neuropsychopharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s11064-005-8836-6","article-title":"Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol","volume":"30","author":"Olsen","year":"2005","journal-title":"Neurochem Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2016.01.002","article-title":"Ethanol-induced GABAA receptor alpha4 subunit plasticity involves phosphorylation and neuroactive steroids","volume":"72","author":"Werner","year":"2016","journal-title":"Mol Cell Neurosci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/383283","article-title":"Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations","volume":"74","author":"Edenberg","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B180","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.b.30091","article-title":"Allelic and haplotypic association of GABRA2 with alcohol dependence","author":"Covault","year":"2004","journal-title":"Am J Med Genet Part B, Neuropsych Genet"},{"key":"B181","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.ypg.0000185027.89816.d9","article-title":"Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis","volume":"16","author":"Fehr","year":"2006","journal-title":"Psychiatr Genet."},{"key":"B182","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jpsychires.2006.11.006","article-title":"GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence","volume":"42","author":"Soyka","year":"2008","journal-title":"J Psychiatr Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pbb.2008.03.007","article-title":"The role of GABA(A) receptors in the development of alcoholism","volume":"90","author":"Enoch","year":"2008","journal-title":"Pharmacol Biochem Behav."},{"key":"B184","first-page":"345","article-title":"Alcohol dependence and genes encoding alpha2 and gamma1 GABAA receptor subunits: insights from humans and mice","volume":"34","author":"Borghese","year":"2012","journal-title":"Alcohol Res."},{"key":"B185","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1073\/pnas.0911109107","article-title":"A genome-wide association study of alcohol dependence","volume":"107","author":"Bierut","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B186","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archgenpsychiatry.2009.83","article-title":"Genome-wide association study of alcohol dependence","volume":"66","author":"Treutlein","year":"2009","journal-title":"Arch Gen Psychiatry."},{"key":"B187","doi-asserted-by":"publisher","first-page":"e29369","DOI":"10.1371\/journal.pone.0029369","article-title":"GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naive P and NP rats","volume":"7","author":"Enoch","year":"2012","journal-title":"PLoS ONE."},{"key":"B188","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.mp.4000554","article-title":"Association between variants at the GABAAbeta2, GABAAalpha6 and GABAAgamma2 gene cluster and alcohol dependence in a Scottish population","volume":"4","author":"Loh","year":"1999","journal-title":"Mol Psychiatry."},{"key":"B189","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3346\/jkms.2006.21.3.533","article-title":"Association between alcoholism and the genetic polymorphisms of the GABAA receptor genes on chromosome 5q33-34 in Korean population","volume":"21","author":"Park","year":"2006","journal-title":"J Korean Med Sci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.biopsych.2009.08.019","article-title":"The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence","volume":"67","author":"Enoch","year":"2010","journal-title":"Biol Psychiatry."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1073\/pnas.0910117107","article-title":"Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptors","volume":"107","author":"Dixon","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B192","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1521-0391.2012.00253.x","article-title":"Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence","volume":"21","author":"Smelson","year":"2012","journal-title":"American Journal on Addictions."},{"key":"B193","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/FBP.0000000000000466","article-title":"Early-life stress influences acute and sensitized responses of adult mice to cocaine by interacting with GABAA alpha2 receptor expression","volume":"30","author":"Dixon","year":"2019","journal-title":"Behav Pharmacol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuropharm.2018.08.021","article-title":"Early-life adversity selectively impairs alpha2-GABA(A) receptor expression in the mouse nucleus accumbens and influences the behavioral effects of cocaine","volume":"141","author":"Mitchell","year":"2018","journal-title":"Neuropharmacology."},{"key":"B195","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0006-8993(00)02858-4","article-title":"Chronic cocaine differentially affects diazepam's anxiolytic and anticonvulsant actions. Relationship to GABA(A) receptor subunit expression","volume":"882","author":"Lilly","year":"2000","journal-title":"Brain Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1523\/JNEUROSCI.2879-19.2020","article-title":"Genetic architecture and molecular neuropathology of human cocaine addiction","volume":"40","author":"Huggett","year":"2020","journal-title":"J Neurosci."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1060949\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T01:18:42Z","timestamp":1673486322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1060949\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":196,"alternative-id":["10.3389\/fpsyt.2022.1060949"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1060949","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1060949"}}